Tirzepatide Bulk Supplier — UK
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports Tirzepatide (CAS: 2023788-19-2) to research institutions in UK. Our WHO-GMP certified facility in India supplies 98%+ purity Tirzepatide for dual GIP/GLP-1 incretin receptor research.
Tirzepatide Export Specifications for UK
| Compound | Tirzepatide |
| CAS Number | 2023788-19-2 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | MHRA |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to UK | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of Tirzepatide
Tirzepatide is used in dual GIP/GLP-1 incretin receptor research. Research institutions in UK source this compound for preclinical studies under applicable MHRA research regulations.
Why UK Researchers Source Tirzepatide from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for MHRA compliance
- Temperature-controlled DHL/FedEx shipping to UK
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in UK
Semaglutide in UK | Retatrutide in UK | Liraglutide in UK | Mazdutide in UK
Tirzepatide — Other Countries
Tirzepatide in USA | Tirzepatide in Germany | Tirzepatide in Australia | Tirzepatide in Canada
Source from India — Key Manufacturing Cities
Tirzepatide in Mumbai, India | Tirzepatide in Delhi, India | Tirzepatide in Hyderabad, India | Tirzepatide in Bangalore, India
Request Tirzepatide for your UK research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
